Pfizer Limited (NSE:PFIZER)

Market Cap	269.41B
Revenue (ttm)	22.81B
Net Income (ttm)	7.68B
Shares Out	45.75M
EPS (ttm)	167.79
PE Ratio	35.10
Forward PE	38.31
Dividend	35.00 (0.61%)
Ex-Dividend Date	Jul 9, 2025

Volume	62,633
Average Volume	127,499
Open	5,788.00
Previous Close	5,776.00
Day's Range	5,773.00 - 5,930.00
52-Week Range	3,701.00 - 6,451.15
Beta	0.18
RSI	82.24
Earnings Date	May 29, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1950
• Employees: 1,721
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PFIZER

Financial Performance

In 2024, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.